Huang A, Cheng J, Zhan Y, Zhou F, Xuan Y, Wang Y
Cell Oncol (Dordr). 2024; 47(4):1405-1423.
PMID: 38568419
DOI: 10.1007/s13402-024-00938-6.
Altaf R, Ilyas U, Ma A, Shi M
Front Oncol. 2023; 13:1206768.
PMID: 37324026
PMC: 10264625.
DOI: 10.3389/fonc.2023.1206768.
Sun F, Yang X, Song W, Yu N, Lin Q
Mol Cell Biochem. 2022; 478(9):1973-1986.
PMID: 36586093
DOI: 10.1007/s11010-022-04646-3.
Li J, Wei B, Feng J, Wu X, Chang Y, Wang Y
Front Endocrinol (Lausanne). 2022; 13:1006480.
PMID: 36583000
PMC: 9792468.
DOI: 10.3389/fendo.2022.1006480.
Zhao M, Qin T, Huang D
Thorac Cancer. 2022; 13(12):1772-1782.
PMID: 35537816
PMC: 9200889.
DOI: 10.1111/1759-7714.14453.
The Biological Fate of a Novel Anticancer Drug Candidate TNBG-5602: Metabolic Profile, Interaction with CYP450, and Pharmacokinetics in Rats.
Li R, Zhou S, Gan Z, Wang L, Yu Y
Molecules. 2022; 27(8).
PMID: 35458793
PMC: 9024597.
DOI: 10.3390/molecules27082594.
Multi-omics analysis of an immune-based prognostic predictor in non-small cell lung cancer.
Zheng Y, Tang L, Liu Z
BMC Cancer. 2021; 21(1):1322.
PMID: 34893051
PMC: 8662860.
DOI: 10.1186/s12885-021-09044-4.
Yang-Yin-Jie-Du decoction overcomes gefitinib resistance in non-small cell lung cancer via down-regulation of the PI3K/Akt signalling pathway.
Chen S, Zhang G, Shu Q
Pharm Biol. 2021; 59(1):1294-1304.
PMID: 34543169
PMC: 8462892.
DOI: 10.1080/13880209.2021.1972122.
Circ_0001944 Contributes to Glycolysis and Tumor Growth by Upregulating NFAT5 Through Acting as a Decoy for miR-142-5p in Non-Small Cell Lung Cancer.
Dou Y, Tian W, Wang H, Lv S
Cancer Manag Res. 2021; 13:3775-3787.
PMID: 34040437
PMC: 8140396.
DOI: 10.2147/CMAR.S302814.
Caspase-8 knockdown suppresses apoptosis, while induces autophagy and chemo-sensitivity in non-small cell lung cancer cells.
Zuo H, Chen C, Ma L, Min Q, Shen Y
Am J Transl Res. 2020; 12(10):6478-6489.
PMID: 33194045
PMC: 7653624.
Detection of circulating genetically abnormal cells in peripheral blood for early diagnosis of non-small cell lung cancer.
Liu W, Zhang B, Chen C, Li Y, Ye X, Tang D
Thorac Cancer. 2020; 11(11):3234-3242.
PMID: 32989915
PMC: 7606026.
DOI: 10.1111/1759-7714.13654.
Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer.
Chen J, Wu R, Xuan Y, Jiang M, Zeng Y
Biosci Rep. 2020; 40(10).
PMID: 32969465
PMC: 7538683.
DOI: 10.1042/BSR20202711.
Circular RNA circ-SLC7A6 acts as a tumor suppressor in non-small cell lung cancer through abundantly sponging miR-21.
Wang Y, Zheng F, Wang Z, Lu J, Zhang H
Cell Cycle. 2020; 19(17):2235-2246.
PMID: 32794418
PMC: 7513860.
DOI: 10.1080/15384101.2020.1806449.
Pathological Mechanistic Studies of Osimertinib Resistance in Non-Small-Cell Lung Cancer Cells Using an Integrative Metabolomics-Proteomics Analysis.
Ma Q, Wang J, Ren Y, Meng F, Zeng L
J Oncol. 2020; 2020:6249829.
PMID: 32256584
PMC: 7103047.
DOI: 10.1155/2020/6249829.
5-HT Receptor Contributes to Proliferation, Migration and Invasion in NSCLC Cells.
Du X, Wang T, Wang Z, Wu X, Gu Y, Huang Q
Onco Targets Ther. 2020; 13:2139-2151.
PMID: 32210580
PMC: 7071786.
DOI: 10.2147/OTT.S244339.
lncRNA JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt/β-catenin signaling.
Pan J, Fang S, Tian H, Zhou C, Zhao X, Tian H
Mol Cancer. 2020; 19(1):9.
PMID: 31941509
PMC: 6961326.
DOI: 10.1186/s12943-020-1133-9.
Placenta-specific 8 is a potential novel target for osimertinib resistance in non-small cell lung cancer.
Fei X, Wang G, Shen H, Gu X
Oncol Lett. 2019; 18(1):955-961.
PMID: 31289574
PMC: 6540393.
DOI: 10.3892/ol.2019.10344.
